NCT02182739

Brief Summary

Evaluation on the amelioration of symptom intensity of the indication and to evaluate drug tolerability.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13,039

participants targeted

Target at P75+ for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2001

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2001

Completed
12.6 years until next milestone

First Submitted

Initial submission to the registry

July 3, 2014

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 8, 2014

Completed
Last Updated

October 29, 2014

Status Verified

July 1, 2014

Enrollment Period

11 months

First QC Date

July 3, 2014

Last Update Submit

October 28, 2014

Conditions

Arthritis, Rheumatoid

Outcome Measures

Primary Outcomes (2)

  • Change in assessment of intensity of pain on a 4-point verbal rating scale

    up to 1 year

  • Assessment of tolerability on a 4-point scale

    up to 1 year

Secondary Outcomes (1)

  • Number of patients with adverse events

    up to 1 year

Study Arms (1)

Meloxicam

Drug: Meloxicam

Interventions

MeloxicamDRUG

tablets or injectable solution

Meloxicam

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

primary care

You may qualify if:

  • Patients according to the physicians medical criteria on the labeled indications for Meloxicam

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Arthritis, Rheumatoid

Interventions

Meloxicam

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System Diseases

Intervention Hierarchy (Ancestors)

ThiazinesSulfur CompoundsOrganic ChemicalsThiazolesAzolesHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 3, 2014

First Posted

July 8, 2014

Study Start

January 1, 2001

Primary Completion

December 1, 2001

Last Updated

October 29, 2014

Record last verified: 2014-07